EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
ObesityType 2 Diabetes
Interventions
DEVICE

EndoBarrier SANS

Eligible subjects will be implanted with the EndoBarrier® SANS™ Device for a period of 3 months. The GI Dynamics' EndoBarrier® SANS™ is an endoscopically positioned device that represents an alternative to the use of gastric bypass operative techniques as a means of re-routing food and altering the gut-hormone axis. The EndoBarrier® SANS™ provides an alternate passage of chime through the duodenum and proximal sixty centimeters of jejunum replicating in part the bypass of bariatric surgery.

Trial Locations (1)

50603

Universiti Malaya Medical Centre, Jalan universiti, Kuala Lumpur

Sponsors
All Listed Sponsors
collaborator

University of Malaya

OTHER

lead

Morphic Medical Inc.

INDUSTRY